Is Caribou Biosciences, Inc. (CRBU) a Buy, Sell, or Hold?
NASDAQ : CRBU
Caribou Biosciences, Inc.
$1.694 USD
-$0.04 (-2.08%)
- Volume
- 1.21M
- Average Volume
- 2.09M
- Market Capitalization
- $168.01M
- P/E Ratio
- -1.22
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.54
- Year Low
- $1.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.22
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
43
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
8
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$35009
CRBU Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CRBU Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kelly Timothy P | officer: Chief Technology Officer | 2026-02-25 | S-Sale | 1.93 | 2026-02-27 |
| Kelly Timothy P | officer: Chief Technology Officer | 2026-02-20 | A-Award | 1.8 | 2026-02-24 |
| Kelly Timothy P | officer: Chief Technology Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| Kelly Timothy P | officer: Chief Technology Officer | 2026-02-24 | S-Sale | 1.96 | 2026-02-24 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2026-02-24 | S-Sale | 1.96 | 2026-02-24 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2026-02-20 | A-Award | 1.8 | 2026-02-24 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2026-02-20 | A-Award | 1.8 | 2026-02-24 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2026-02-24 | S-Sale | 1.96 | 2026-02-24 |
| Albertson Tina M. | officer: Chief Medical Officer | 2026-02-20 | A-Award | 1.8 | 2026-02-24 |
| Albertson Tina M. | officer: Chief Medical Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| Albertson Tina M. | officer: Chief Medical Officer | 2026-02-24 | S-Sale | 1.96 | 2026-02-24 |
| Zheng Ran | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Whiting Nancy | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Sacks Natalie | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Richardson-Heron Dara | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| JOHNSON DAVID LEE | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| GUGGENHIME ANDREW | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Braunstein Scott | director | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Ryali Sriram | officer: Chief Financial Officer | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Ryali Sriram | officer: Chief Financial Officer | 2026-02-20 | A-Award | 0 | 2026-02-20 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2026-02-20 | A-Award | 1.8 | 2026-02-20 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2026-02-20 | A-Award | 0 | 2026-02-20 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2025-03-14 | P-Purchase | 1.02 | 2025-03-17 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2025-02-20 | A-Award | 0 | 2025-02-21 |
| Albertson Tina M. | officer: Chief Medical Officer | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Albertson Tina M. | officer: Chief Medical Officer | 2025-02-20 | A-Award | 0 | 2025-02-21 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2025-02-20 | A-Award | 0 | 2025-02-21 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2025-02-21 | S-Sale | 1.35 | 2025-02-21 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2025-02-20 | A-Award | 0 | 2025-02-21 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2025-02-21 | S-Sale | 1.35 | 2025-02-21 |
| Kelly Timothy P | officer: Chief Technology Officer | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Kelly Timothy P | officer: Chief Technology Officer | 2025-02-20 | A-Award | 0 | 2025-02-21 |
| Kanner Steven | officer: Chief Scientific Officer | 2025-02-20 | A-Award | 0 | 2025-02-21 |
| Kanner Steven | officer: Chief Scientific Officer | 2025-02-21 | S-Sale | 1.35 | 2025-02-21 |
| Kanner Steven | officer: Chief Scientific Officer | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Zheng Ran | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Whiting Nancy | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Sacks Natalie | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Richardson-Heron Dara | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| JOHNSON DAVID LEE | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| GUGGENHIME ANDREW | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Braunstein Scott | director | 2025-02-20 | A-Award | 1.41 | 2025-02-21 |
| Ryali Sriram | officer: Chief Financial Officer | 2025-01-29 | P-Purchase | 1.42 | 2025-01-30 |
| Ryali Sriram | officer: Chief Financial Officer | 2025-01-10 | A-Award | 1.64 | 2025-01-10 |
| Ryali Sriram | officer | 2025-01-02 | 0 | 2025-01-10 | |
| Fischesser Ryan | officer: VP of Finance and Controller | 2024-11-20 | A-Award | 0 | 2024-11-22 |
| Fischesser Ryan | officer: VP of Finance and Controller | 2024-09-27 | 0 | 2024-10-04 | |
| Fischesser Ryan | officer: VP of Finance and Controller | 2024-09-27 | 6.81 | 2024-10-04 | |
| Fischesser Ryan | officer: VP of Finance and Controller | 2024-09-27 | 4.11 | 2024-10-04 | |
| Fischesser Ryan | officer: VP of Finance and Controller | 2024-09-27 | 6.12 | 2024-10-04 | |
| Fischesser Ryan | officer: VP of Finance and Controller | 2024-09-27 | 15.16 | 2024-10-04 | |
| Albertson Tina M. | officer: Chief Medical Officer | 2024-08-19 | A-Award | 2.18 | 2024-08-20 |
| Albertson Tina M. | officer | 2024-08-12 | 0 | 2024-08-20 | |
| O'Byrne Jason | officer: Chief Financial Officer | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| O'Byrne Jason | officer: Chief Financial Officer | 2024-02-20 | A-Award | 0 | 2024-02-22 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2024-02-20 | A-Award | 0 | 2024-02-22 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2024-02-20 | A-Award | 0 | 2024-02-22 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2024-02-20 | A-Award | 0 | 2024-02-22 |
| Kanner Steven | officer: Chief Scientific Officer | 2024-02-20 | A-Award | 0 | 2024-02-22 |
| Kanner Steven | officer: Chief Scientific Officer | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Zheng Ran | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Whiting Nancy | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Sacks Natalie | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Richardson-Heron Dara | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| JOHNSON DAVID LEE | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| GUGGENHIME ANDREW | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Braunstein Scott | director | 2024-02-20 | A-Award | 6.81 | 2024-02-22 |
| Kanner Steven | officer: Chief Scientific Officer | 2024-02-06 | M-Exempt | 2.69 | 2024-02-08 |
| Kanner Steven | officer: Chief Scientific Officer | 2024-02-06 | M-Exempt | 2.69 | 2024-02-08 |
| Kelly Timothy P | officer | 2024-01-01 | 0 | 2024-01-10 | |
| Kelly Timothy P | officer: Chief Technology Officer | 2024-01-08 | A-Award | 5.74 | 2024-01-09 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2023-06-08 | M-Exempt | 2.96 | 2023-06-09 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2023-06-08 | M-Exempt | 2.96 | 2023-06-09 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2023-03-20 | M-Exempt | 2.96 | 2023-03-22 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2023-03-20 | M-Exempt | 2.96 | 2023-03-22 |
| Haurwitz Rachel E. | director, officer: President and CEO | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Kanner Steven | officer: Chief Scientific Officer | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Richardson-Heron Dara | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Khan Ruhi Ahmad | officer: Chief Business Officer | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Sacks Natalie | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Braunstein Scott | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| GUGGENHIME ANDREW | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| MCCLUNG BARBARA G | officer: Chief Legal Officer | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Rizvi Syed Ali-aamir | officer: Chief Medical Officer | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Zheng Ran | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Whiting Nancy | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| O'Byrne Jason | officer: Chief Financial Officer | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| JOHNSON DAVID LEE | director | 2023-02-21 | A-Award | 6.12 | 2023-02-23 |
| Rizvi Syed Ali-aamir | officer: Chief Medical Officer | 2023-01-19 | S-Sale | 6.31 | 2023-01-20 |
| Kanner Steven | officer: Chief Scientific Officer | 2022-12-02 | M-Exempt | 2.69 | 2022-12-02 |
| Kanner Steven | officer: Chief Scientific Officer | 2022-12-02 | M-Exempt | 2.69 | 2022-12-02 |
| Fischesser Ryan | officer: VP of Finance and Controller | 2022-10-06 | M-Exempt | 4.11 | 2022-10-07 |